Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2020-08-20 Regulatory Filings
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
109年08月法人說明會簡報 — 411920200820M001.pdf
Regulatory Filings
2020-08-20 Chinese
109年08月法人說明會簡報
Investor Presentation Classification · 90% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, and links to presentation materials (PDF files). The content focuses on the scheduling and availability of investor presentations rather than the presentation content itself or financial results. The document length is short (695 characters) and primarily serves as an announcement or summary of investor presentation events. Therefore, it fits best under the category 'Investor Presentation' (IP).
2020-08-20 Chinese
公告本公司受宏遠證券邀請參加法人說明會
Regulatory Filings Classification · 95% confidence The document is a short announcement (616 characters) about the company 4119 旭富 being invited to participate in an investor presentation (法人說明會) on 109/08/20. It provides details such as date, time, location, and a brief summary of the event (explaining the company's operational overview). It also directs readers to the official site for full financial information. There is no actual financial data or detailed report content included, only an announcement of the event. According to the 'Menu vs Meal' rule, this is an announcement of an investor presentation, not the presentation itself. Therefore, the correct classification is Investor Presentation (IP). However, since this is only an announcement of the event and not the presentation material itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the event. Given the short length and nature, RNS is the most appropriate classification with high confidence.
2020-08-19 Chinese
109年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by company insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or other report types. The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the document is best classified as a Director's Dealing report.
2020-08-11 Chinese
109年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 旭富製藥科技股份有限公司, including directors, independent directors, general managers, and other executives. It lists the number of shares held, pledged shares, and related ratios. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 3152 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the appropriate classification is DIRS with high confidence.
2020-08-11 Chinese
109年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about loan balances and guarantee endorsements, all of which are zero. It is a short, factual update without detailed financial statements or analysis. It does not contain any report or announcement of a report publication, nor does it include management commentary or regulatory certifications. The content fits best as a general regulatory announcement or compliance disclosure that does not fit into more specific categories.
2020-08-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.